Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review

Thoma, Christian, Day, Christopher P., Trenell, Michael I.·2012·Journal of Hepatology
DOI 10.1016/j.jhep.2011.06.010

Cited by (523)

Items 201–300 of 523

  1. Effect of lifestyle modification education based on health belief model in overweight/obese patients with non-alcoholic fatty liver disease: A parallel randomized controlled clinical trial
    Mojgan Nourian, Gholamreza Askari, Parastoo Golshiri, Maryam Sadat Miraghajani, Saeideh Shokri, Arman Arab · 2020 · Clinical Nutrition ESPEN
  2. Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests
    Agostino Di Ciaula, Giuseppe Calamita, Harshitha Shanmugam, Mohamad Khalil, Leonilde Bonfrate, David Q.‐H. Wang, György Baffy, Piero Portincasa · 2021 · International Journal of Molecular Sciences
  3. Mediterranean diet for the management of metabolic dysfunction‐associated steatotic liver disease in non‐Mediterranean, Western countries: What's known and what's needed?
    Ayesha Sualeheen, Sze‐Yen Tan, Ekavi N. Georgousopoulou, Robin M. Daly, Audrey C. Tierney, Stuart Keith Roberts, Elena S. George · 2024 · Nutrition Bulletin
  4. 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine—recommendations for facing obesity, fatty liver and fibrosis epidemics
    Francesca Maria Trovato, Daniela Catalano, Giuseppe Musumeci, Guglielmo M. Trovato · 2014 · The EPMA Journal
  5. Fatty Liver Disease
    DINA G. TINIAKOS, Quentin Mark Anstee, Alastair D. Burt · 2017 · Elsevier eBooks
  6. Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults
    Irene Cantero, Mariana Elorz, Itziar Abete, Bertha Araceli Marín-Alejandre, José Ignacio Herrero, Jose Ignacio Monreal, Alberto Benito, Jorge Augusto Quiroga, Ana Martínez, Ma Pilar Huarte et al. · 2018 · International Journal of Medical Sciences
  7. An energy-restricted high-protein diet supplemented with β-cryptoxanthin alleviated oxidative stress and inflammation in nonalcoholic fatty liver disease: a randomized controlled trial
    Fatemeh Haidari, Abdollah Hojhabrimanesh, Bijan Helli, Seyed Saeed Seyedian, Kambiz Ahmadi Angali · 2019 · Nutrition Research
  8. Alcoholic liver disease/nonalcoholic fatty liver disease index
    Ivana B. Cerović, Dušan R. Mladenović, Rada Ješić, Tamara Naumović, Miloš Branković, Danijela B. Vučević, Vuk Aleksić, Tatjana S. Radosavljević · 2013 · European Journal of Gastroenterology & Hepatology
  9. The effects of ipragliflozin on the liver-to-spleen attenuation ratio as assessed by computed tomography and on alanine transaminase levels in Japanese patients with type 2 diabetes mellitus
    Yoshiyuki Bando, Ayumi Ogawa, Kazuhide Ishikura, Hideo Kanehara, Azusa Hisada, Kazuo Notumata, Kazuhiro Okafuji, Daisyu Toya · 2017 · Diabetology International
  10. Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
    Zhiqing Zhang, Hong Yang, Fei Han, Peng Guo · 2025 · Current Issues in Molecular Biology
  11. Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience
    Jeremy Cobbold, Sarrah Raveendran, Christopher M Peake, Quentin Mark Anstee, Michael S. Yee, Mark R. Thursz · 2013 · Frontline Gastroenterology
  12. Physical Activity, Fatty Liver, and Glucose Metabolism Over the Life Course: The Lifelines Cohort
    Oyuntugs Byambasukh, Dorien M. Zelle, Eva Corpeleijn · 2019 · The American Journal of Gastroenterology
  13. Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally
    Ma Ai Thanda Han, Qi Yu, Zaid Tafesh, Nikolaos Pyrsopoulos · 2020 · Journal of Clinical and Translational Hepatology
  14. Management of fatty liver disease with the metabolic syndrome
    Mariana Verdelho Machado, Helena Cortez‐Pinto · 2014 · Expert Review of Gastroenterology & Hepatology
  15. The effect of minimal dietary changes with raisins in NAFLD patients with non-significant fibrosis: a randomized controlled intervention
    Andriana C. Kaliora, Alexander D. Kokkinos, Anastasia Diolintzi, Maria G. Stoupaki, Aristea Gioxari, Panagiotis T. Kanellos, George V. Dedoussis, Jiannis Vlachogiannakos, Constantinos Revenas, Spiros D. Ladas et al. · 2016 · Food & Function
  16. Cardiorespiratory Fitness and Risk of Fatty Liver
    Kristiina S. Pälve, Katja Pahkala, Emmi Suomela, Heikki Aatola, Janne Hulkkonen, Markus Juonala, Terho J. Lehtimäki, Tapani Rönnemaa, Jorma S.A. Viikari, Mika A. P. Kähönen et al. · 2017 · Medicine & Science in Sports & Exercise
  17. Therapy for Nonalcoholic Fatty Liver Disease: Current Options and Future Directions
    Patrick T. Campbell, Allison Symonds, Alfred Sidney Barritt · 2021 · Clinical Therapeutics
  18. Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD
    Moolla, Ahmad, Poolman, Toryn, Othonos, Nantia, Dong, Jiawen, Smith, Kieran, Cornfield, Thomas, White, Sarah, Ray, David W., Mouchti, Sofia, Mózes, Ferenc E. et al. · 2025 · JHEP Reports
  19. Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future
    Stefano Gitto, Giovanni Vitale, Erica Villa, Pietro Andreoné · 2015 · Gastroenterology Research and Practice
  20. Anti-inflammatory diet consumption reduced fatty liver indices
    Mitra Darbandi, Behrooz Hamzeh, Azad Ayenepour, Shahab Rezaeian, Farid Najafi, Ebrahim Shakiba, Yahya Pasdar · 2021 · Scientific Reports
  21. Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss
    Anne‐Laure Borel, Julie‐Anne Nazare, Aurélie Baillot, Natalie Alméras, Angelo Tremblay, Jean Bergeron, Paul Poirier, Jean‐Pierre Després · 2016 · American Journal of Physiology-Endocrinology and Metabolism
  22. Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Chun Kit Hung, Henry Charles Bodenheimer · 2017 · Clinics in Liver Disease
  23. Myricetin alleviated hepatic steatosis by acting on microRNA-146b/thyroid hormone receptor b pathway in high-fat diet fed C57BL/6J mice
    Shufang Xia, Yu-Yu Qiu, Li‐Mei Chen, Yu-Yu Jiang, Wei Huang, Zhen-Xing Xie, Xue Tang, Jin Sun · 2019 · Food & Function
  24. Updated S2k clinical practice guideline on non-alcoholic fatty liver disease (NAFLD) issued by the German society of gastroenterology, digestive and metabolic diseases (DGVS)–April 2022–AWMF Registration No.: 021–025
    Authors, Collaborators: · 2022 · Zeitschrift für Gastroenterologie
  25. Effect of Exercise on Liver Function and Insulin Resistance Markers in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Hejazi, Keyvan, Hackett, Daniel · 2023 · Journal of Clinical Medicine
  26. Research advances in the diagnosis and treatment of MASLD/MASH
    Dekai Wang, Jinxian Miao, Lihua Zhang, Lin Zhang · 2024 · Annals of Medicine
  27. Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)
    Lucía Lavín-Alconero, Tatiana Fernández-Lanas, Paula Iruzubieta, M. Arias, Juan Carlos Rodríguez-Duque, Coral Rivas, María Luisa Cagigal, Coral Montalbán, Antonio López Useros, Ana Álvarez-Cancelo et al. · 2021 · Trials
  28. Esteatohepatitis no alcohólica
    Manuel Romero‐Gómez · 2022 · Medicina Clínica
  29. Adipose tissue-derived stem cells promote the reversion of non-alcoholic fatty liver disease: An in vivo study
    Naishun Liao, Fan Pan, Yingchao Wang, Youshi Zheng, Bo Xu, Wenwei Chen, Yunzhen Gao, Zhixiong Cai, Xiaolong Liu, Jingfeng Liu · 2016 · International Journal of Molecular Medicine
  30. Decrease in waist-to-hip ratio reduced the development of chronic kidney disease in non-obese non-alcoholic fatty liver disease
    Young Eun Chon, Hyung Jong Kim, Yu Bum Choi, Seong Gyu Hwang, Kyu Sung Rim, Mi Na Kim, Joo Ho Lee, Yeonjung Ha, Mi‐Jung Lee · 2020 · Scientific Reports
  31. Network pharmacology analysis to explore mechanism of Three Flower Tea against nonalcoholic fatty liver disease with experimental support using high-fat diet-induced rats
    Peixuan Wu, Shufei Liang, Yanping He, Rui Lv, Bendong Yang, Meng Wang, Chao Wang, Yong Li, Xinhua Song, Wenlong Sun · 2022 · Chinese Herbal Medicines
  32. Low fat diet versus low carbohydrate diet for management of non-alcohol fatty liver disease: A systematic review
    Hamed Kord‐Varkaneh, Faezeh Poursoleiman, Mohammad Khaldoun Al Masri, Kamar Allayl Alras, Yamen Shayah, Mohd Diya Masmoum, Fulwah Abdulaziz Alangari, Abd Alras, Giulia Rinaldi, Andrew Stewart Day et al. · 2022 · Frontiers in Nutrition
  33. A Pilot Randomised Study of the Metabolic and Histological Effects of Exercise in Non-alcoholic Steatohepatitis
    Ingrid J. Hickman · 2013 · Journal of Diabetes & Metabolism
  34. Osteosarcopenia in NAFLD/MAFLD: an underappreciated clinical problem in chronic liver disease
    Musio, Alessandra, Perazza, Federica, Leoni, Laura, Stefanini, Bernardo, Dajti, Elton, Menozzi, Renata, Petroni, Maria Letizia, Colecchia, Antonio, Ravaioli, Federico · 2023 · International Journal of Molecular Sciences
  35. Enhanced Amelioration of High-Fat Diet-Induced Fatty Liver by Docosahexaenoic Acid and Lysine Supplementations
    Hsin‐Yu Lin, Chih-Chien Chen, Yu-Jen Chen, Yuan‐Yu Lin, Harry John Mersmann, Shih‐Torng Ding · 2014 · BioMed Research International
  36. Updates in Metabolic Dysfunction‐Associated Fatty Liver Disease (MAFLD) in Children
    Kushila Rupasinghe, Jonathan M. Hind, Robert Hegarty · 2023 · Journal of Pediatric Gastroenterology and Nutrition
  37. Circulating ALT Levels in Healthy Volunteers Over Life-Span: Assessing Aging Paradox and Nutritional Implications
    Harry G. Preuss, Gilbert R. Kaats, Nate Mrvichin, Debasis Bagchi, Jeffrey M. Preuss · 2019 · Journal of the American College of Nutrition
  38. Nonalcoholic fatty liver disease: a cohort study focusing on treatment response to nutritional counseling
    Tâmara Oliveira dos Reis, Silvia Marinho Ferolla, Maria Luíza Pereira Lima, Maria Arlene Fausto, Ana Cristina Lopes Albricker, Geyza Nogueira de Almeida Armiliato, Clara Gontijo Camelo, Lucas Paschoal Horta Gomes, Teresa Cristina Abreu Ferrari, Cláudia Alves Couto · 2015 · Medical Express
  39. Obesity and Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ): A Literature Review on Pathophysiology and Treatment
    Michael Romanos, Juan Martin Garcia Cordova, Jose L. Villamarin, Juan Diego Pazmino Zurita, Andres Acosta · 2026 · Diabetes Obesity and Metabolism
  40. Novel glucose-lowering drugs for non-alcoholic fatty liver disease
    Zuodi Fu, Xiaoling Cai, Wenjia Yang, Ming-Ming Zhao, Ran Li, Yufeng Li · 2021 · World Journal of Diabetes
  41. A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice
    Mary P. Moore, Rory P. Cunningham, Rachel A. H. Davis, Sarah E. Deemer, Brandon M. Roberts, Eric P. Plaisance, R. Scott Rector · 2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  42. Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD)
    Ignazio Grattagliano, Agostino Di Ciaula, Jacek Baj, Emilio Molina‐Molina, Harshitha Shanmugam, Gabriella Garruti, David Q.‐H. Wang, Piero Portincasa · 2021 · Methods in molecular biology
  43. The safety and efficacy evaluation of sodium-glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty liver disease: An updated meta-analysis
    Man-Qiu Mo, Zichun Huang, Yuzhen Liang, Yunhua Liao, Ning Xia · 2021 · Digestive and Liver Disease
  44. Nutritional Approaches in Children with Overweight or Obesity and Hepatic Steatosis
    Chiara Spiezia, Claudia Di Rosa, Danilo Fintini, Pietro Ferrara, Laura De Gara, Yeganeh Manon Khazrai · 2023 · Nutrients
  45. Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis‐4 Score
    Stuart C. Gordon, Nandita Kachru, Emily D. Parker, Stephanie Korrer, Ahmet Burak Ozbay, Robert J. Wong · 2020 · Hepatology Communications
  46. Metabolic and Hepatic Effects of Energy‐Reduced Anti‐Inflammatory Diet in Younger Adults with Obesity
    Gordana Kenđel Jovanović, Ines Mrakovčić-Šutić, Sandra Pavičić Žeželj, Indira Benjak Horvat, Lucia Šuša, Dario Rahelić, Sanja Klobučar Majanović · 2021 · Canadian Journal of Gastroenterology and Hepatology
  47. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways
    Haiyan Zhang, Wen‐Jun Shen, Yuan Cortez, Fredric B. Kraemer, Salman Azhar · 2012 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  48. Epidemiology and Natural History of Nafld/Epidemiologija I Prirodna Istorija Nealkoholne Masne Jetre
    Claudia Della Corte, Federica Ferrari, Alberto Villani, Valério Nobili · 2014 · Journal of Medical Biochemistry
  49. Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease.
    R. Aller, Daniel Antonio de Luis, Olatz Izaola, B de la Fuente, Rosario Bachiller · 2014 · PubMed
  50. Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals
    Kahei Au, Ming-Hua Zheng, Wei‐Jei Lee, Omar M. Ghanem, Kamal Kumar Mahawar, Asim Shabbir, Carel Wynand le Roux, Giovanni Targher, Christopher D. Byrne, Yusuf Yilmaz et al. · 2024 · Current Obesity Reports
  51. Effect of Progressive Resistance Exercise Training on Hepatic Fat in Asian Indians with Non-Alcoholic Fatty Liver Disease
    Kirti Damor, Kanchan Mittal, Ashu Seith Bhalla, Rita Sood, Ravindra Mohan Pandey, Randeep Guleria, Kalpana Luthra, Naval K. Vikram · 2014 · Journal of Advances in Medicine and Medical Research
  52. γ‐Glutamyltransferase and Risk of Sudden Cardiac Death in Middle‐Aged Finnish Men: A New Prospective Cohort Study
    Setor Kwadzo Kunutsor, Hassan Khan, Jari Antero Laukkanen · 2016 · Journal of the American Heart Association
  53. Examining the Relationship Between Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome in Nondiabetic Subjects
    Harry G. Preuss, Gilbert R. Kaats, Nate Mrvichin, Anand Swaroop, Debasis Bagchi, Dallas L. Clouatre, Jeffrey M. Preuss · 2018 · Journal of the American College of Nutrition
  54. Knowledge, Attitude, and Practice Toward Lifestyle Modification Among Diabetes Mellitus Patients Attending the University of Gondar Comprehensive Specialized Hospital Northwest, Ethiopia
    Chilot Kassa Mekonnen, Hailemichael Kindie Abate, Eleni Tesfaye Tegegne · 2020 · Diabetes Metabolic Syndrome and Obesity
  55. Histological severity of nonalcoholic fatty liver disease is associated with 10-year risk for atherosclerotic cardiovascular disease
    Ji‐Hye Park, Bo Kyung Koo, Won Kyum Kim, Won–Ho Kim · 2021 · Hepatology International
  56. Yellow Himalayan Raspberry (Rubus ellipticus Sm.): Ethnomedicinal, Nutraceutical, and Pharmacological Aspects
    Ananda Lamichhane, Gopal Lamichhane, Hari Prasad Devkota · 2023 · Molecules
  57. Sedentary behaviour, physical activity, and NAFLD: Curse of the chair
    Michael I. Trenell · 2015 · Journal of Hepatology
  58. Macronutrient composition and its effect on body composition changes during weight loss therapy in patients with non-alcoholic fatty liver disease: Secondary analysis of a randomized controlled trial
    Catarina Lindqvist, Magnus Holmer, Hannes Hagström, Sven Petersson, Veronika Tillander, Torkel B. Brismar, Per I Stal · 2023 · Nutrition
  59. Baicalin ameliorates high fat diet‐induced nonalcoholic fatty liver disease in mice via adenosine monophosphate‐activated protein kinase‐mediated regulation of SREBP1 /Nrf2/ NF‐κB signaling pathways
    Yanxia Gao, Jingbo Liu, Zhili Hao, Na Sun, Jianhua Guo, Xiaozhong Zheng, Panpan Sun, Wei Hsian Yin, Kuohai Fan, Hongquan Li · 2023 · Phytotherapy Research
  60. Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
    Pin‐Nan Cheng, Wen‐Jone Chen, Charles Jia‐Yin Hou, Chih‐Lin Lin, Ming‐Ling Chang, Chia‐Chi Wang, Wei‐Ting Chang, Chao‐Yung Wang, Chun‐Yen Lin, Chung‐Lieh Hung et al. · 2023 · Clinical and Molecular Hepatology
  61. Diet-induced non-alcoholic fatty liver disease affects expression of major cytochrome P450 genes in a mouse model
    Tsuyoshi Chiba, Keiko Noji, Shohei Shinozaki, Sachina Suzuki, Keizo Umegaki, Kentaro Shimokado · 2016 · Journal of Pharmacy and Pharmacology
  62. Nonalcoholic Fatty Liver Disease
    Samer Gawrieh · 2016 · Springer eBooks
  63. NAFLD in clinical practice: Can simple blood and anthropometric markers be used to detect change in liver fat measured by 1H‐ MRS ?
    Shelley Elizabeth Keating, Helen M. Parker, Ingrid J. Hickman, Sjaan R. Gomersall, Matthew P. Wallen, Jeff Scott Coombes, Graeme A. Macdonald, Jacob George, Nathan Anthony Johnson · 2017 · Liver International
  64. PMFs-rich Citrus extract prevents the development of non-alcoholic fatty liver disease in C57BL/6J mice induced by a high-fat diet
    Zunli Ke, Ziyan Zhao, Yuanyuan Zhao, Xiaodan Xu, Yin Li, Si Tan, Cheng Huang, Zhiqin Zhou · 2018 · Journal of Functional Foods
  65. ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury
    Yankun Zhang, Yu‐Chen Fan, Huili Hu, Xiaohui Zhang, Zehua Wang, Zhuanchang Wu, Liyuan Wang, Xiangguo Yu, Xiaojia Song, Xiang Hua Peng et al. · 2023 · Nature Communications
  66. Republished: Non-alcoholic fatty liver disease: a practical approach to treatment
    Jessica Katharine Dyson, Quentin Mark Anstee, Stuart McPherson · 2015 · Postgraduate Medical Journal
  67. Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample
    Marion Flechtner‐Mors, Samuel Nelson George, Suemeyra Oeztuerk, Mark Martin Haenle, Wolfgang Köenig, Armin Imhof, Bernhard Otto Boehm, Tilmann Graeter, Richard A Mason, Wolfgang Kratzer et al. · 2014 · BMC Research Notes
  68. Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice
    Jef Verbeek, Pieter Spincemaille, Ilse Vanhorebeek, Greet Van den Berghe, Ingrid Vander Elst, Petra Windmolders, Jos F. van Pelt, Van der Merwe, Pierre Bédossa, Frederik Nevens et al. · 2017 · Lipids in Health and Disease
  69. Importance of Active Participation in Obesity Management Through Mobile Health Care Programs: Substudy of a Randomized Controlled Trial
    Bumjo Oh, Ga-Hye Yi, Min Kyu Han, Jong S. Kim, Chang Hee Lee, Belong Cho, Hee‐Cheol Kang · 2018 · JMIR mhealth and uhealth
  70. Nutritional Status and Nutrition Quality in Patients with Non-Alcoholic Fatty Liver Disease
    Darija Vranešić Bender · 2017 · Acta Clinica Croatica
  71. Acceptability of alginate enriched bread and its effect on fat digestion in humans
    David Houghton, Matthew D. Wilcox, Iain A. Brownlee, Peter Ian Chater, Chris J. Seal, Jeffrey P. Pearson · 2019 · Food Hydrocolloids
  72. Practical approach to non‐alcoholic fatty liver disease in patients with diabetes
    Foong Way David Tai, Wing‐Kin Syn, William Alazawi · 2015 · Diabetic Medicine
  73. Intermittent calorie restriction largely counteracts the adverse health effects of a moderate‐fat diet in aging C57BL/6J mice
    Fenni Rusli, Carolien Lute, Mark V. Boekschoten, Miriam van Dijk, Klaske van Norren, Aswin L. Menke, Michael M. Müller, Wilma T. Steegenga · 2016 · Molecular Nutrition & Food Research
  74. The Association of Hispanic Ethnicity with Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome
    Monika A. Sarkar, Norah A. Terrault, Caroline C. Duwaerts, Phyllis C. Tien, Marcelle Ivonne Cedars, Heather Gibson Huddleston · 2018 · Current Opinion in Gynecology and Obstetrics
  75. Effectiveness of two physical activity programs on non-alcoholic fatty liver disease. a randomized controlled clinical trial
    Isabella Franco, Antonella Bianco, Marı́a del Pilar Dı́az, Caterina Bonfiglio, Marisa Chiloiro, Sonia Alejandra Pou, Julia Becaría Coquet, Antonella Mirizzi, Alessandro Nitti, Angelo Campanella et al. · 2019 · Revista de la Facultad de Ciencias Médicas de Córdoba
  76. Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
    Jaehyun Bae, Eugene Han, Hye Won Lee, Cheol‐Young Park, Choon Hee Chung, Dae Ho Lee, E.H. Cho, Eun‐Jung Rhee, Ji Hee Yu, Ji Hyun Park et al. · 2024 · Diabetes & Metabolism Journal
  77. Role of Exercise in Optimizing the Functional Status of Patients with Nonalcoholic Fatty Liver Disease
    Lynn H. Gerber, Ali A. Weinstein, Lisa Renee Pawloski · 2013 · Clinics in Liver Disease
  78. Association of dietary insulinaemic potential and odds of non‐alcoholic fatty liver disease among adults: A case–control study
    Mohammad Hassan Sohouli, Ali Akbar Sayyari, Abolfazl Lari, Ghazaleh Nameni, Mojtaba Lotfi, Somaye Fatahi, Solaleh Saneie, Mihnea‐Alexandru Găman, Farzan Moodi, Pourya Raee et al. · 2021 · Journal of Human Nutrition and Dietetics
  79. High Prevalence of Hepatic Fibrosis, Measured by Elastography, in a Population-Based Study of Mexican Americans
    Gordon P. Watt, Miryoung Lee, Jen‐Jung Pan, Michael B. Fallon, Rohit Seth Loomba, Laura Beretta, Joseph B. McCormick, Susan P. Fisher‐Hoch · 2018 · Clinical Gastroenterology and Hepatology
  80. Combined Beneficial Effect of Voluntary Physical Exercise and Vitamin D Supplementation in Diet-induced Obese C57BL/6J Mice
    Alexandra Marziou, BENJAMIN AUBERT, Charlène Couturier, Julien Astier, Clothilde Philouze, Philippe Obert, Jean‐François Landrier, CATHERINE RIVA · 2021 · Medicine & Science in Sports & Exercise
  81. Exercise in NAFLD: Just do it
    Shelley Elizabeth Keating, Leon Anton Adams · 2016 · Journal of Hepatology
  82. Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management
    Mariangela Rondanelli, Sara Borromeo, Alessandro Cavioni, Clara Gasparri, Ilaria Gattone, Elisa Genovese, Alessandro Lazzarotti, Leonardo Minonne, Alessia Moroni, Zaira Patelli et al. · 2025 · Metabolites
  83. The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD
    Ariel Sasson, Eva Kristoferson, Rogério Oliveira Batista, John Arthur McClung, Nader G. Abraham, Stephen J. Peterson · 2020 · Archives of Biochemistry and Biophysics
  84. A systematic review and meta-analysis of randomized controlled trials to evaluate plant-based omega-3 polyunsaturated fatty acids in nonalcoholic fatty liver disease patient biomarkers and parameters
    Ella Moore, Imran Patanwala, Alireza Jafari, Ian Glynn Davies, Richard Kirwan, Lisa Newson, Mohsen Mazidi, Katie Elizabeth Lane · 2023 · Nutrition Reviews
  85. Diagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review
    Basile M. Njei, Prince Addo. Ameyaw, Yazan A. Al‐Ajlouni, Lea‐Pearl Njei, Sarpong Boateng · 2024 · Cureus
  86. Dietary treatment of nonalcoholic steatohepatitis
    Emily Rothbaum Perito, Luis A. Rodríguez, Robert H. Lustig · 2012 · Current Opinion in Gastroenterology
  87. Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice
    Simone Coghetto Acedo · 2015 · World Journal of Hepatology
  88. Adiponectin mediates the additive effects of combining daily exercise with caloric restriction for treatment of non-alcoholic fatty liver
    Junghwan Cho, Yeojung Koh, Ji Min Han, Da Yeong Kim, T-K Kim, Hyun‐Sik Kang · 2016 · International Journal of Obesity
  89. Fatty liver index and left ventricular mass: prospective associations from two independent cohorts
    Xiang Li, Jarkko S. Heiskanen, Hao Ma, Yoriko Heianza, Yajun Guo, Tanika N. Kelly, Hua He, Vivian Andrew Fonseca, Wei Chen, Emily Wheeler Harville et al. · 2021 · Journal of Hypertension
  90. Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?
    Athanasia Mitsala, Christos Tsalikidis, Κonstantinos Romanidis, Michail S. Pitiakoudis · 2022 · Current Oncology
  91. Non-alcoholic fatty liver disease
    Michael Pavlides, Jeremy Cobbold · 2015 · Medicine
  92. Liver enzymes and psychological well-being response to aerobic exercise training in patients with chronic hepatitis C
    SM El-Kader, OH Al-Jiffri, Fadwa M Al-Shreef · 2014 · African Health Sciences
  93. Nonalcoholic fatty liver disease remission in men through regular exercise
    Takafumi Osaka, Yoshitaka Hashimoto, Masahide Hamaguchi, Takao Kojima, Akihiro Obora, Michiaki Fukui · 2018 · Journal of Clinical Biochemistry and Nutrition
  94. Independent Association of Physical Activity with Nonalcoholic Fatty Liver Disease and Alanine Aminotransferase Levels
    Dong Kee Jang, Jungsoo Lee, Jun Kyu Lee, Yeo Hyung Kim · 2019 · Journal of Clinical Medicine
  95. Nr2e1 ablation impairs liver glucolipid metabolism and induces inflammation, high-fat diets amplify the damage
    Qing Xiong, Yuwen Wu, Miao Yang, Guijun Wu, Ye Wang, Huawei Wang, Jieyuan Feng, Linyang Song, Beier Tong, Guangzhen He et al. · 2019 · Biomedicine & Pharmacotherapy
  96. Nonalcoholic fatty liver disease and cardiovascular disease phenotypes
    Giandomenico Bisaccia, Fabrizio Ricci, Cesare Mantini, Claudio Tana, Gian Luca Romani, Cosima Schiavone, Sabina Gallina · 2020 · SAGE Open Medicine
  97. Decoding liver injury: A regulatory role for histone modifications
    Wenfang Tian, Yong Xu · 2015 · The International Journal of Biochemistry & Cell Biology
  98. Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic.
    Marialena Mouzaki, Johane P. Allard · 2012 · Europe PMC (PubMed Central)
  99. The association of dietary inflammatory index (DII) and central obesity with non-alcoholic fatty liver disease (NAFLD) in people with diabetes (T2DM)
    Samira Soltanieh, Marieh Salavatizadeh, Hossein Poustchi, Zahra Yari, Asieh Mansour, Mohammad E. Khamseh, Mojtaba Malek, Fariba Alaei-Shahmiri, Azita Hekmatdoost · 2023 · Heliyon
  100. Young Adult Physical Activity Trajectories and Midlife Nonalcoholic Fatty Liver Disease
    Junia Nogueira de Brito, Daniel J. McDonough, Mahesh Mathew, Lisa B. VanWagner, Pamela J. Schreiner, Kelley Pettee Gabriel, David R. Jacobs, James Greg Terry, J. Jeffrey Carr, Mark A. Pereira · 2023 · JAMA Network Open